InvestorsHub Logo
Post# of 252642
Next 10
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

Re: DewDiligence post# 98167

Thursday, 07/01/2010 6:59:32 AM

Thursday, July 01, 2010 6:59:32 AM

Post# of 252642
The difference in disease progression between placebo and provenge was only 0.2 weeks favoring provenge so patients would likely be reintroduced to chemo and the total cost would be provenge + chemo. So it would appear that the total cost when treating a patient with provenge would be higher especially since the patient lives longer after disease progresses.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.